Partnering/Licensing Activities
About Otsuka Group
The Otsuka group of companies is a global enterprise with central hubs for R&D and commercialization in the US, Europe, and Asia. Our approximately 47,000 employees across 200 companies in 33 countries and regions take on challenges across various fields and themes to help fulfill the universal wish of people to be healthy. As one of the group companies, Otsuka Pharmaceutical Co., Ltd. pursues external collaborations as a key strategy to advance innovation.
Sales Ratio
* Rest of the world
Otsuka's Partnering Focus
Leverage strategic partnership to address important unmet medical needs in
neuroscience, nephrology, and oncology.
Asset Strategy
- Unique and novel mechanism of action
- Significant differentiation with competitors
Therapeutic Area
- Global Asset
Neuroscience / Kidney diseases / Autoimmune /
Oncology (Hematology)* - Japan / Asia Asset
Above mentioned plus:
Gastrointestinal disorders / Cardiovascular diseases / Ophthalmology / Dermatology
- Excluding US
Target Development Stage
- Global Asset
Preclinical (within 2 years to IND)
P1, P2, P3, Filing, Approval, Launch - Japan/Asia Asset
POC proven in US / EU
Drug Modality
- Small molecules
- Large molecules
- Peptides
- Allogeneic cell therapy
- Nucleic acid
- Gene therapy
Inquiry Form
- Fill out the form
- Confirm your inquiry
- Complete
Otsuka Pharmaceutical welcomes your questions and feedback. Please fill out the form below, before proceeding to "Confirm your inquiry" step.
The personal information you provide will be used for the purpose of answering your inquiry. Your personal contact information may be provided to Otsuka Pharmaceutical Co., Ltd., and any of its affiliated companies involved in the manufacture and sale of the product concerned. It will not be provided to any third parties, except relevant contractors. Other personal information will be managed appropriately according to the laws of Japan, and based on the Otsuka Pharmaceutical Co., Ltd. Website Privacy Policy.
Fields marked with * are mandatory.
Please note that we may not be able to respond to your online inquiry. Also we may need some time to respond to your inquiry. We appreciate for your patience.